Sectors
NNVC
NanoViricides, Inc.
1.54
3 x 1.53
1 x 1.54
bid
ask
-
0.06
3.75%
09:56 AM
timesize
| Ytd | 36.28% | |
| 1y | -9.41% |
1.53
day range
1.59
0.85
52 week range
2.23
| Open | 1.54 | Prev Close | 1.60 | Low | 1.53 | High | 1.59 | Mkt Cap | 28.59M |
| Vol | 213.29K | Avg Vol | 940.94K | EPS | -0.43 | P/E | -3.72 | Forward P/E | -2.68 |
| Beta | 1.67 | Short Ratio | 1.92 | Inst. Own | 9.42% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-15 | 50-d Avg | 1.52 | 200-d Avg | 1.30 | 1yr Est | 6.50 |
NNVC News
benzinga.com
NanoViricides Gets National Ethics Committee Approval For Phase II Clinical Study Of NV-387 Oral Gum
NanoViricides, Inc. (NYSE:NNVC) (the "Company"), a clinical stage leader developing antivira
benzinga.com
Noble Capital Markets Initiates Coverage On Nanoviricides with Outperform Rating, Announces Price Ta
Noble Capital Markets analyst Robert LeBoyer initiates coverage on Nanoviricides (AMEX:NNVC) with
benzinga.com
NanoViricides Continues To Advance Broad-Spectrum Antiviral Drug NV-387 Towards Phase II Clinical Tr
NanoViricides, Inc. (NYSE:NNVC) (the "Company"), a clinical stage leader developing antivira
benzinga.com
FDA's Office Of Orphan Products Development Grants Rare Pediatric Disease Drug Designation To NanoVi
NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a c
benzinga.com
NanoViricides Ships NV-387 Oral Gummies To The Democratic Republic of Congo Ahead Of Patient Enrollm
Clinical Trial Site preparations are being performed by our CRO in India, Om Sai Clinical Research P
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
Why Semtech Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
Semtech Corp (SMTC) reported strong Q1 financial results, beating analysts' estimates. Shares ro
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.